Kanada -
engelska -
Health Canada
imodium complete chewable tablets tablet (chewable)
mcneil consumer healthcare division of johnson & johnson inc - loperamide hydrochloride; simethicone - tablet (chewable) - 2mg; 125mg - loperamide hydrochloride 2mg; simethicone 125mg - antidiarrhea agents
Kanada -
engelska -
Health Canada
diarrhea relief liquid gels capsule
pharmascience inc - loperamide hydrochloride - capsule - 2mg - loperamide hydrochloride 2mg - antidiarrhea agents
Kanada -
engelska -
Health Canada
jamp loperamide capsule
jamp pharma corporation - loperamide hydrochloride - capsule - 2mg - loperamide hydrochloride 2mg
Kanada -
engelska -
Health Canada
imodium quick dissolve tablet (orally disintegrating)
mcneil consumer healthcare division of johnson & johnson inc - loperamide hydrochloride - tablet (orally disintegrating) - 2mg - loperamide hydrochloride 2mg - antidiarrhea agents
Kanada -
engelska -
Health Canada
imodium calming liquid solution
mcneil consumer healthcare division of johnson & johnson inc - loperamide hydrochloride - solution - 2mg - loperamide hydrochloride 2mg - antidiarrhea agents
Kanada -
engelska -
Health Canada
imodium complete tablet
mcneil consumer healthcare division of johnson & johnson inc - loperamide hydrochloride; simethicone - tablet - 2mg; 125mg - loperamide hydrochloride 2mg; simethicone 125mg - antidiarrhea agents
Irland -
engelska -
HPRA (Health Products Regulatory Authority)
imodium plus 2mg/125mg tablets
imbat limited - dimethicone; loperamide hydrochloride - tablet - 2 mg/125 milligram(s) - antipropulsives; loperamide
Malta -
engelska -
Medicines Authority
imodium 2mg capsules
neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - loperamide hydrochloride - hard capsule - loperamide hydrochloride 2 mg - antidiarrheals, intestinal antiinflammatory/antiinfective agents
USA -
engelska -
NLM (National Library of Medicine)
imodium- loperamide hydrochloride capsule
mcneil consumer healthcare - loperamide hydrochloride (unii: 77ti35393c) (loperamide - unii:6x9oc3h4ii) - capsule - 2 mg - imodium® (loperamide hydrochloride) is indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease. imodium® is also indicated for reducing the volume of discharge from ileostomies. imodium is contraindicated in patients with a known hypersensitivity to loperamide hydrochloride or to any of the excipients. imodium is contraindicated in patients with abdominal pain in the absence of diarrhea. imodium is not recommended in infants below 24 months of age. imodium should not be used as the primary therapy: a specific clinical study designed to assess the abuse potential of loperamide at high doses resulted in a finding of extremely low abuse potential. studies in morphine-dependent monkeys demonstrated that loperamide hydrochloride at doses above those recommended for humans prevented signs of morphine withdrawal. however, in humans, the naloxone challenge pupil test, which when positive indicates opiate-like effects, performed
